Sarda Proteins Ltd (BOM:519242)
India · Delayed Price · Currency is INR 112.61
+5.36 (5.00%)
At close: Sep 11, 2026
Sarda Proteins Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,011 | 758 | 215 | 93 | 100 | 64 | |
Market Cap Growth | 327.17% | 252.19% | 131.92% | -6.87% | 54.85% | 256.60% |
Enterprise Value | 937 | 759 | 213 | 92 | 99 | 64 |
Last Close Price | 112.61 | 84.48 | 124.75 | 53.79 | 57.76 | 37.30 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 14.27 | 118.87 | 4221.69 | 478.54 | - | 20.94 |
PS Ratio | 5.55 | 4.69 | 0.89 | 7.16 | 1.72 | 0.60 |
PB Ratio | 33.51 | 25.14 | 9.05 | 3.91 | 4.24 | 2.70 |
P/TBV Ratio | 33.51 | 25.14 | 9.05 | 3.91 | 4.24 | 2.70 |
P/FCF Ratio | - | - | - | - | - | 61.76 |
P/OCF Ratio | - | - | - | - | - | 61.76 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 5.15 | 4.69 | 0.88 | 7.12 | 1.72 | 0.60 |
EV/EBITDA Ratio | - | 261.56 | - | - | - | 23.72 |
EV/EBIT Ratio | - | 262.01 | 1092.24 | - | - | 23.77 |
EV/FCF Ratio | - | - | - | - | - | 61.56 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.05 | 0.05 | - | - | - | - |
Debt / EBITDA Ratio | - | 0.53 | - | - | - | - |
Net Debt / Equity Ratio | -2.44 | -2.44 | -0.01 | -0.05 | -0.08 | -0.14 |
Net Debt / EBITDA Ratio | - | -25.36 | - | - | 1.26 | -1.20 |
Net Debt / FCF Ratio | - | 0.10 | 0.31 | 0.51 | 0.61 | -3.13 |
Asset Turnover | - | 0.36 | 9.52 | 0.54 | 2.39 | 4.69 |
Quick Ratio | - | 0.14 | 0.14 | 6.45 | 7.97 | 14.80 |
Current Ratio | - | 1.03 | 10.51 | 124.96 | 98.07 | 62.92 |
Return on Equity (ROE) | - | 23.65% | 0.21% | 0.82% | -1.39% | 13.77% |
Return on Assets (ROA) | - | 0.40% | 0.48% | -3.78% | -3.78% | 7.36% |
Return on Invested Capital (ROIC) | - | - | 0.21% | -6.62% | 17.74% | 11.75% |
Return on Capital Employed (ROCE) | - | 9.60% | 0.80% | -6.10% | -6.20% | 11.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.76% | 0.84% | 0.02% | 0.21% | -0.33% | 4.78% |
FCF Yield | -75.57% | -100.74% | -0.51% | -2.49% | -3.02% | 1.62% |
Buyback Yield / Dilution | -108.47% | 0.11% | - | - | - | - |